Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Scholar Rock Holding Corporation - Common Stock (NQ:SRRK)

29.68 +1.02 (+3.56%)
Official Closing Price Updated: 4:15 PM EDT, Oct 24, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Scholar Rock Holding Corporation - Common Stock

< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
Scholar Rock to Present Apitegromab Clinical Data from the TOPAZ Phase 2 Trial in Patients with Type 2 and 3 Spinal Muscular Atrophy at the 2021 Virtual SMA Research & Clinical Care Meeting
From Scholar Rock
Via Business Wire
Scholar Rock to Present at Upcoming Healthcare Conferences in June
From Scholar Rock
Via Business Wire
42 Stocks Moving In Tuesday's Mid-Day Session
Gainers SemiLEDs Corporation (NASDAQ: LEDS) shares surged 28.4% to $10.17 following reports indicating equipment billings increased 50% in April compared to the prior year's... 
Via Benzinga
25 Stocks Moving in Tuesday's Pre-Market Session
Gainers U.S. Well Services, Inc. (NASDAQ: USWS) rose 30.5% to $1.25 in pre-market trading after the company reported commitment to becoming all-electric hydraulic facturing... 
Via Benzinga
A Peek Into The Markets: US Stock Futures Rise Ahead Of Economic Reports
Pre-open movers U.S. stock futures traded higher in early pre-market trade after the Nasdaq surged over 1% in the previous session. Investors are awaiting earnings results from... 
Via Benzinga
7 Stocks Moving In Monday's After-Hours Session
Gainers Scholar Rock (NASDAQ: SRRK) shares are trading higher after the company announced it received FDA Fast Track designation for apitegromab for the treatment of patients... 
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
Gainers OptiNose (NASDAQ:OPTN) stock rose... 
Via Benzinga
Scholar Rock Receives Fast Track Designation from the U.S. FDA for Apitegromab for the Treatment of Patients with Spinal Muscular Atrophy
From Scholar Rock
Via Business Wire
Scholar Rock to Present Trials in Progress Poster for SRK-181 DRAGON Phase 1 Clinical Trial at the American Society of Clinical Oncology Annual Meeting
From Scholar Rock
Via Business Wire
Scholar Rock Reports First Quarter 2021 Financial Results and Highlights Business Progress
From Scholar Rock
Via Business Wire
Scholar Rock Announces Publication of Phase 1 Clinical Trial Data Evaluating Apitegromab in Healthy Volunteers in the Journal Advances in Therapy
From Scholar Rock
Via Business Wire
The Daily Biotech Pulse: Lilly, Novartis Trail Q1 Estimates, Exec Departure At Applied Genetics, Patent Award For Scholar Rock, Aldeyra Data Readout
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 26) 10x Genomics, Inc. (NASDAQ... 
Via Benzinga
Topics Intellectual Property
Scholar Rock Announces Issuance of U.S. Patent Broadly Relevant to Inhibitors of Myostatin Activation
From Scholar Rock, Inc.
Via Business Wire
Scholar Rock Stock Shows Market Leadership With Healthy Jump To 83 RS Rating
When looking for the best stocks to buy and watch, focus on those with rising relative price strength. Scholar Rock stock fits that bill. 
Via Investor's Business Daily
Scholar Rock Presents Biomarker Strategy to Support the SRK-181 DRAGON Phase 1 Proof-of-Concept Trial at the American Association for Cancer Research Annual Meeting
From Scholar Rock, Inc.
Via Business Wire
51 Biggest Movers From Yesterday
Gainers UTime Limited (NASDAQ: UTME) shares jumped 875% to close at $39.00 on Tuesday after the company priced its IPO at $4 per share. Romeo Power, Inc. (NYSE: RMO) climbed 59.6... 
Via Benzinga
Topics Initial Public Offering
Mid-Afternoon Market Update: Dow Falls 50 Points; Scienjoy Shares Spike Higher
Toward the end of trading Tuesday, the Dow traded down 0.15% to 33,475 while the NASDAQ rose 0.12% to 13,721.59. The S&P also rose, gaining 0.03% to 4,078.98. The U.S. has the... 
Via Benzinga
Topics Stocks
12 Health Care Stocks Moving In Tuesday's Intraday Session
Gainers Second Sight Medical (NASDAQ:EYES) stock increased by 33.37% to $9.87 during Tuesday's regular session. As of 12:32 EST, this security is trading at a volume... 
Via Benzinga
Mid-Day Market Update: Crude Oil Rises Over 2%; Scholar Rock Shares Plunge
Midway through trading Tuesday, the Dow traded down 0.05% to 33,510.72 while the NASDAQ rose 0.48% to 13,771.47. The S&P also rose, gaining 0.20% to 4,086.01. The U.S. has the... 
Via Benzinga
Topics Stocks
Why Scholar Rock Shares Dropped Despite Positive Apitegromab Data In Spinal Muscular Atrophy
Scholar Rock (NASDAQ: SRRK) shares dropped despite the company reporting positive 12-month data on spinal muscular atrophy (SMA) candidate apitegromab. The 12... 
Via Benzinga
33 Stocks Moving In Tuesday's Mid-Day Session
Gainers Scienjoy Holding Corporation (NASDAQ: SJ) shares jumped 67.4% to $16.04 after the company announced a strategic alliance with Snipp to launch a new loyalty and rewards... 
Via Benzinga
< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.